Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Doug Drysdale
Recent news which mentions Doug Drysdale
Psychedelics Policy Is Shifting In Washington: Here's What One Biotech CEO Sees Coming
June 03, 2025
Tickers
CYBN
Tags
FDA
Matthew Zorn
Benzinga
From
Benzinga
Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression
November 13, 2024
Tickers
CYBN
Tags
Psychedelics
neuropsychiatry company
neuropsychiatric treatment
From
Benzinga
Cybin Reports Access To $101M To Sustain Deuterated Psychedelics Programs, Q2 Numbers & 2024 Goals
November 15, 2023
Tickers
CYBN
Tags
Psychedelics
Earnings
Markets
From
Benzinga
Cybin Stock Down On Laying Off 15% Of Workforce As Part Of A Streamlining Clinical Alignment
February 23, 2023
Tickers
CYBN
Tags
Cannabis
News
Doug Drysdale
From
Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
February 01, 2023
Tickers
CYBN
DMT
Tags
first/in/human dosing
Doug Drysdale
CYB004
From
Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
September 27, 2022
Tickers
CYBN
MSSTF
Tags
CYBN
Market News
Penny Stocks
From
Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
August 30, 2022
Tickers
CYBN
Tags
Health Care
Psilocybin
Psychedelics
From
Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
Tickers
CYBN
DEA
MDD
Tags
Psychedelics
MDD
Psilocybin
From
Benzinga
Cybin's Psilocybin Analog CYB003 Gets FDA Clearance For Trial To Potentially Treat Major Depressive Disorder
June 28, 2022
Tickers
CYBN
Tags
Benzinga
News
Biotech
From
Benzinga
Cybin Closes Fiscal Year 2022, Reports Financial Results And Major Achievements
June 22, 2022
Tickers
CYBN
Tags
Benzinga
Cannabis
News
From
Benzinga
Elon Musk Says Psychedelics Should Be Seriously Considered For Therapeutic Uses, Leading Chorus Of Celeb Support
June 10, 2022
Tickers
CYBN
TWTR
Tags
Joe Rogan
Doug Drysdale
TWTR
From
Benzinga
Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin
June 07, 2022
Tickers
CYBE
CYBN
ENTBF
Tags
Psychedelics
Timothy Ko
Centre for Human Drug Research (CHDR)
From
Benzinga
Major Depressive Disorder Could Soon Have Treatment Option Via Cybin's Psilocybin Analog
May 31, 2022
Tickers
CYBN
Tags
FDA
Benzinga
News
From
Benzinga
Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp
April 22, 2022
Tickers
CYBN
Tags
CYBN
Market News
Clinilabs Drug Development Corporation
From
Benzinga
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
April 19, 2022
Tickers
CYBN
DMT
PCC
Tags
Benzinga
DMT
Cannabis
From
Benzinga
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
April 06, 2022
Tickers
AGN
CYBN
PTX
Tags
News
Small Business
Cannabis
From
Benzinga
Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event
February 14, 2022
Tickers
CYBN
FTRP
MMDCF
PSYC
Tags
Robert Barrow
Benzinga
MMDCF
From
Benzinga
Cybin Obtains U.S. Patent For Is Proprietary Compound Deuterated DMT Aimed At Treating Anxiety Disorders
February 09, 2022
Tickers
CYBN
Tags
Doug Drysdale
Benzinga
News
From
Benzinga
Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana
January 11, 2022
Tickers
CYBN
FTRP
WSNAF
Tags
Markets
Government
Dr/ Nathan Bryson
From
Benzinga
Why Cybin Shares Are Rising
January 11, 2022
Tickers
CYBN
Tags
Market News
CYBN
Penny Stocks
From
Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Tickers
CYBN
Tags
Market News
CYBN
Earnings
From
Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
November 08, 2021
Tickers
CYBN
Tags
Market News
CYBN
Penny Stocks
From
Benzinga
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
Tickers
CMPS
CYBN
FLHLF
NMLSF
Tags
Market News
CYBN
Penny Stocks
From
Benzinga
Cybin Becomes First Psychedelics Company On The NYSE: CEO Explains Everything You Need To Know
August 05, 2021
Tickers
CLXPF
CMPS
GBNH
Tags
Market News
Markets
psychedelics
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit